Clinical Trials Directory

Trials / Unknown

UnknownNCT02143349

The Effect of Coleus Forskohlii Extract on the Risk Factors of Metabolic Syndrome

Investigation of Appetite Suppressant Properties Associated With Coleus Forskohlii in Overweight and Obese Individuals

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Olive Lifesciences Pvt Ltd · Industry
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Coleus forskohlii extract contains the bioactive compound, forskolin. Preliminary studies have shown that forskolin can increase fat metabolism thus reduce fat accumulation in both animals and humans. It has been suggested that forskolin may also suppress appetite thus reduce energy intake and results in weight loss. This study will evaluate the appetite suppressant properties of Coleus forskohlii extract. In addition the effect on central obesity and risk factors of metabolic syndrome will also be investigated.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTColeus forskohlii extractIngestion of 250 mg Coleus forskohlii extract capsule twice a day for 12 weeks
OTHERPlaceboIngestion of 250 mg placebo capsule twice a day for 12 weeks

Timeline

Start date
2014-04-01
Primary completion
2015-05-01
Completion
2015-05-01
First posted
2014-05-21
Last updated
2014-05-21

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT02143349. Inclusion in this directory is not an endorsement.